Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion.

Xiu Y, Dong Q, Fu L, Bossler A, Tang X, Boyce B, Borcherding N, Leidinger M, Sardina JL, Xue HH, Li Q, Feldman A, Aifantis I, Boccalatte F, Wang L, Jin M, Khoury J, Wang W, Hu S, Yuan Y, Wang E, Yuan J, Janz S, Colgan J, Habelhah H, Waldschmidt T, Müschen M, Bagg A, Darbro B, Zhao C.

Blood. 2020 Jan 9;135(2):108-120. doi: 10.1182/blood.2019001438.

PMID:
31697816
2.

Draft Genome Sequences of Six Lactobacillus gasseri and Three Lactobacillus paragasseri Strains Isolated from the Female Bladder.

Putonti C, Akhnoukh V, Anagnostopoulos Z, Bilek M, Colgan J, El Idrissi S, Magnuszewski K, Marino S, Szymulewski M, Tyahla M, Yanchuk V, Miller-Ensminger T, Batrich M, Brassil B, Mormando R, Johnson G, Wolfe AJ.

Microbiol Resour Announc. 2019 Sep 12;8(37). pii: e00973-19. doi: 10.1128/MRA.00973-19.

3.

Systematic Study of L-Shell Opacity at Stellar Interior Temperatures.

Nagayama T, Bailey JE, Loisel GP, Dunham GS, Rochau GA, Blancard C, Colgan J, Cossé P, Faussurier G, Fontes CJ, Gilleron F, Hansen SB, Iglesias CA, Golovkin IE, Kilcrease DP, MacFarlane JJ, Mancini RC, More RM, Orban C, Pain JC, Sherrill ME, Wilson BG.

Phys Rev Lett. 2019 Jun 14;122(23):235001. doi: 10.1103/PhysRevLett.122.235001.

PMID:
31298873
4.

Triple differential cross sections for electron-impact ionization of methane at intermediate energy.

Ali E, Granados C, Sakaamini A, Harvey M, Ancarani LU, Murray AJ, Dogan M, Ning C, Colgan J, Madison D.

J Chem Phys. 2019 May 21;150(19):194302. doi: 10.1063/1.5097670.

PMID:
31117797
5.

Recombination of Protons Accelerated by a High Intensity High Contrast Laser.

Tata S, Mondal A, Sarkar S, Jha J, Ved Y, Lad AD, Colgan J, Pasley J, Krishnamurthy M.

Phys Rev Lett. 2018 Sep 28;121(13):134801. doi: 10.1103/PhysRevLett.121.134801.

PMID:
30312093
6.

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

Padrnos L, Ernst B, Dueck AC, Kosiorek HE, Ginos BF, Toro A, Johnston PB, Habermann TM, Leis JF, Mikhael JR, Nowakowski GS, Colgan J, Porrata L, Ansell SM, Witzig TE, Reeder C.

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):664-672.e2. doi: 10.1016/j.clml.2018.06.013. Epub 2018 Jun 15.

PMID:
30104176
7.

A male with multiple cardiac masses.

Indrabhinduwat M, Arciniegas Calle MC, Colgan JP, Villarraga HR.

Echo Res Pract. 2018 Sep;5(3):K53-K58. doi: 10.1530/ERP-18-0023. Epub 2018 Jun 12.

8.

Affluent-Born White Mother's Descending Neighborhood Income and Infant Mortality: A Population-Based Study.

Collins JW Jr, Colgan J, Rankin KM, Desisto C.

Matern Child Health J. 2018 Oct;22(10):1484-1491. doi: 10.1007/s10995-018-2544-8.

PMID:
29948760
9.

A man with multiple cardiac masses.

Indrabhinduwat M, Arciniegas Calle MC, Colgan JP, Villarraga BN.

Echo Res Pract. 2018 Jun 12. pii: ERP-18-0023. doi: 10.1530/ERP-18-0023. [Epub ahead of print]

10.

Collisional heating and adiabatic expansion of warm dense matter with intense relativistic electrons.

Coleman JE, Colgan J.

Phys Rev E. 2017 Jul;96(1-1):013208. doi: 10.1103/PhysRevE.96.013208. Epub 2017 Jul 13.

PMID:
29347078
11.

Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function.

Gorman JV, Colgan JD.

Immunology. 2018 Jul;154(3):418-433. doi: 10.1111/imm.12890. Epub 2018 Feb 8.

12.

Development, Implementation, and Evaluation of Active Lions: A Campaign to Promote Active Travel to a University Campus.

Bopp M, Sims D, Matthews SA, Rovniak LS, Poole E, Colgan J.

Am J Health Promot. 2018 Mar;32(3):536-545. doi: 10.1177/0890117117694287. Epub 2017 Feb 19.

PMID:
29214813
13.

A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod.

Stitt DW, Boes CJ, Flanagan EP, Howard MT, Colgan JP.

Mult Scler Relat Disord. 2018 Jan;19:115-117. doi: 10.1016/j.msard.2017.11.014. Epub 2017 Nov 16.

PMID:
29190574
14.

Authors' response.

Evans KS, Wood CM, Moffitt AH, Colgan JA, Holman JK, Marshall SD, Pope DS, Sample LB, Sherman SL, Sinclair PM, Trulove TS.

Am J Orthod Dentofacial Orthop. 2017 Sep;152(3):293-294. doi: 10.1016/j.ajodo.2017.05.018. No abstract available.

PMID:
28863903
15.

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance).

Witzig TE, LaPlant B, Habermann TM, McPhail E, Inwards DJ, Micallef IN, Colgan JP, Nowakowski GS, Ansell SM, Johnston PB.

Blood Cancer J. 2017 Jun 23;7(6):e576. doi: 10.1038/bcj.2017.57. No abstract available.

16.

Compact acceleration of energetic neutral atoms using high intensity laser-solid interaction.

Dalui M, Trivikram TM, Colgan J, Pasley J, Krishnamurthy M.

Sci Rep. 2017 Jun 20;7(1):3871. doi: 10.1038/s41598-017-04152-3.

17.

Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.

Epperla N, Pham AQ, Burnette BL, Wiseman GA, Habermann TM, Macon WR, Ansell SM, Inwards DJ, Micallef IN, Johnston PB, Markovic SN, Porrata LF, Colgan JP, Ristow KM, Nowakowski GS, Witzig TE.

Br J Haematol. 2017 Aug;178(3):427-433. doi: 10.1111/bjh.14688. Epub 2017 May 3.

PMID:
28466487
18.

Early B Cell Progenitors Deficient for GON4L Fail To Differentiate Due to a Block in Mitotic Cell Division.

Barr JY, Goodfellow RX, Colgan DF, Colgan JD.

J Immunol. 2017 May 15;198(10):3978-3988. doi: 10.4049/jimmunol.1602054. Epub 2017 Apr 5.

19.

Sixteen-week analysis of unaltered elastomeric chain relating in-vitro force degradation with in-vivo extraction space tooth movement.

Evans KS, Wood CM, Moffitt AH, Colgan JA, Holman JK, Marshall SD, Pope DS, Sample LB, Sherman SL, Sinclair PM, Trulove TS.

Am J Orthod Dentofacial Orthop. 2017 Apr;151(4):727-734. doi: 10.1016/j.ajodo.2016.10.020.

PMID:
28364896
20.

Sharing Patient-Generated Data in Clinical Practices: An Interview Study.

Zhu H, Colgan J, Reddy M, Choe EK.

AMIA Annu Symp Proc. 2017 Feb 10;2016:1303-1312. eCollection 2016.

21.

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

Rosenthal A, Dueck AC, Ansell S, Gano K, Conley C, Nowakowski GS, Camoriano J, Leis JF, Mikhael JR, Keith Stewart A, Inwards D, Dingli D, Kumar S, Noel P, Gertz M, Porrata L, Russell S, Colgan J, Fonseca R, Habermann TM, Kapoor P, Buadi F, Leung N, Tiedemann R, Witzig TE, Reeder C.

Am J Hematol. 2017 May;92(5):467-472. doi: 10.1002/ajh.24693. Epub 2017 Mar 22.

22.

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

Bennani NN, LaPlant BR, Ansell SM, Habermann TM, Inwards DJ, Micallef IN, Johnston PB, Porrata LF, Colgan JP, Markovic SN, Nowakowski GS, Macon WR, Reeder CB, Mikhael JR, Northfelt DW, Ghobrial IM, Witzig TE.

Am J Hematol. 2017 May;92(5):448-453. doi: 10.1002/ajh.24671. Epub 2017 Mar 10.

23.

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB.

JAMA Oncol. 2017 Sep 1;3(9):1257-1265. doi: 10.1001/jamaoncol.2016.5763. Review.

24.

Comment on "Large Enhancement in High-Energy Photoionization of Fe XVII and Missing Continuum Plasma Opacity".

Blancard C, Colgan J, Cossé P, Faussurier G, Fontes CJ, Gilleron F, Golovkin I, Hansen SB, Iglesias CA, Kilcrease DP, MacFarlane JJ, More RM, Pain JC, Sherrill M, Wilson BG.

Phys Rev Lett. 2016 Dec 9;117(24):249501. doi: 10.1103/PhysRevLett.117.249501. Epub 2016 Dec 9. No abstract available.

PMID:
28009220
25.

Electron impact ionization dynamics of para-benzoquinone.

Jones DB, Ali E, Ning CG, Colgan J, Ingólfsson O, Madison DH, Brunger MJ.

J Chem Phys. 2016 Oct 28;145(16):164306.

PMID:
27802623
26.

Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial.

Johnston PB, LaPlant B, McPhail E, Habermann TM, Inwards DJ, Micallef IN, Colgan JP, Nowakowski GS, Ansell SM, Witzig TE.

Lancet Haematol. 2016 Jul;3(7):e309-16. doi: 10.1016/S2352-3026(16)30040-0. Epub 2016 Jun 5.

27.

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution.

Kenderian SS, Habermann TM, Macon WR, Ristow KM, Ansell SM, Colgan JP, Johnston PB, Inwards DJ, Markovic SN, Micallef IN, Thompson CA, Porrata LF, Martenson JA, Witzig TE, Nowakowski GS.

Blood. 2016 Apr 21;127(16):1960-6. doi: 10.1182/blood-2015-08-665505. Epub 2016 Feb 2.

28.

Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activation.

Phong BL, Avery L, Sumpter TL, Gorman JV, Watkins SC, Colgan JD, Kane LP.

J Exp Med. 2015 Dec 14;212(13):2289-304. doi: 10.1084/jem.20150388. Epub 2015 Nov 23.

29.

Electron- and photon-impact ionization of furfural.

Jones DB, Ali E, Nixon KL, Limão-Vieira P, Hubin-Franskin MJ, Delwiche J, Ning CG, Colgan J, Murray AJ, Madison DH, Brunger MJ.

J Chem Phys. 2015 Nov 14;143(18):184310. doi: 10.1063/1.4935444.

PMID:
26567665
30.

Nonlinear increase of X-ray intensities from thin foils irradiated with a 200 TW femtosecond laser.

Faenov AY, Colgan J, Hansen SB, Zhidkov A, Pikuz TA, Nishiuchi M, Pikuz SA, Skobelev IY, Abdallah J, Sakaki H, Sagisaka A, Pirozhkov AS, Ogura K, Fukuda Y, Kanasaki M, Hasegawa N, Nishikino M, Kando M, Watanabe Y, Kawachi T, Masuda S, Hosokai T, Kodama R, Kondo K.

Sci Rep. 2015 Sep 2;5:13436. doi: 10.1038/srep13436.

31.

An Examination of Workplace Influences on Active Commuting in a Sample of University Employees.

Bopp M, Sims D, Colgan J, Rovniak L, Matthews SA, Poole E.

J Public Health Manag Pract. 2016 Jul-Aug;22(4):387-91. doi: 10.1097/PHH.0000000000000337.

PMID:
26322795
32.

The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma.

Witzig TE, Reeder C, Han JJ, LaPlant B, Stenson M, Tun HW, Macon W, Ansell SM, Habermann TM, Inwards DJ, Micallef IN, Johnston PB, Porrata LF, Colgan JP, Markovic S, Nowakowski GS, Gupta M.

Blood. 2015 Jul 16;126(3):328-35. doi: 10.1182/blood-2015-02-629543. Epub 2015 Apr 28.

33.

A higher-than-predicted measurement of iron opacity at solar interior temperatures.

Bailey JE, Nagayama T, Loisel GP, Rochau GA, Blancard C, Colgan J, Cosse P, Faussurier G, Fontes CJ, Gilleron F, Golovkin I, Hansen SB, Iglesias CA, Kilcrease DP, MacFarlane JJ, Mancini RC, Nahar SN, Orban C, Pain JC, Pradhan AK, Sherrill M, Wilson BG.

Nature. 2015 Jan 1;517(7532):56-9. doi: 10.1038/nature14048.

PMID:
25557711
34.

Survival in patients with limited-stage peripheral T-cell lymphomas.

Briski R, Feldman AL, Bailey NG, Lim MS, Ristow K, Habermann TM, Macon WR, Inwards DJ, Colgan JP, Nowakowski GS, Kaminski MS, Witzig TE, Ansell SM, Wilcox RA.

Leuk Lymphoma. 2015 Jun;56(6):1665-70. doi: 10.3109/10428194.2014.963078. Epub 2014 Oct 30.

35.

Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma.

Witzig TE, Maurer MJ, Habermann TM, Link BK, Micallef IN, Nowakowski GS, Ansell SM, Colgan JP, Inwards DJ, Porrata LF, Markovic SN, Johnston PB, Lin Y, Thompson C, Gupta M, Katzmann JA, Cerhan JR.

Am J Hematol. 2014 Dec;89(12):1116-20. doi: 10.1002/ajh.23839. Epub 2014 Sep 26.

36.

Response to Comment on "Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection".

Gorman JV, Colgan JD.

J Immunol. 2014 Jul 15;193(2):467-8. doi: 10.4049/jimmunol.1401297. No abstract available.

37.

The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas.

Briski R, Feldman AL, Bailey NG, Lim MS, Ristow K, Habermann TM, Macon WR, Inwards DJ, Colgan JP, Nowakowski GS, Kaminski MS, Witzig TE, Ansell SM, Wilcox RA.

Blood Cancer J. 2014 May 30;4:e214. doi: 10.1038/bcj.2014.34.

38.

Identification of hematopoietic-specific regulatory elements from the CD45 gene and use for lentiviral tracking of transplanted cells.

Duong KL, Das S, Yu S, Barr JY, Jena S, Kim E, Zavazava N, Colgan JD, Xue HH, Levasseur DN.

Exp Hematol. 2014 Sep;42(9):761-72.e1-10. doi: 10.1016/j.exphem.2014.05.005. Epub 2014 May 20.

39.

Regulation of T cell responses by the receptor molecule Tim-3.

Gorman JV, Colgan JD.

Immunol Res. 2014 Aug;59(1-3):56-65. doi: 10.1007/s12026-014-8524-1. Review.

40.

Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infection.

Gorman JV, Starbeck-Miller G, Pham NL, Traver GL, Rothman PB, Harty JT, Colgan JD.

J Immunol. 2014 Apr 1;192(7):3133-42. doi: 10.4049/jimmunol.1302290. Epub 2014 Feb 24.

41.

Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.

Porrata LF, Ristow KM, Habermann TM, Witzig TE, Colgan JP, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Nowakowski G, Thompson CA, Markovic SN.

Leuk Lymphoma. 2014 Dec;55(12):2728-38. doi: 10.3109/10428194.2014.893313. Epub 2014 Mar 19.

PMID:
24547705
42.

Recurrent Ebstein-Barr virus-associated diffuse large B-cell lymphoma in an ascending aorta graft.

Bonnichsen CR, Dearani JA, Maleszewski JJ, Colgan JP, Williamson EE, Ammash NM.

Circulation. 2013 Sep 24;128(13):1481-3. doi: 10.1161/CIRCULATIONAHA.113.001427. No abstract available.

PMID:
24060945
43.

Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource.

Link BK, Maurer MJ, Nowakowski GS, Ansell SM, Macon WR, Syrbu SI, Slager SL, Thompson CA, Inwards DJ, Johnston PB, Colgan JP, Witzig TE, Habermann TM, Cerhan JR.

J Clin Oncol. 2013 Sep 10;31(26):3272-8. doi: 10.1200/JCO.2012.48.3990. Epub 2013 Jul 29.

44.

Ejection of quasi-free-electron pairs from the helium-atom ground state by single-photon absorption.

Schöffler MS, Stuck C, Waitz M, Trinter F, Jahnke T, Lenz U, Jones M, Belkacem A, Landers AL, Pindzola MS, Cocke CL, Colgan J, Kheifets A, Bray I, Schmidt-Böcking H, Dörner R, Weber T.

Phys Rev Lett. 2013 Jul 5;111(1):013003. Epub 2013 Jul 2.

45.

Bowel perforation in intestinal lymphoma: incidence and clinical features.

Vaidya R, Habermann TM, Donohue JH, Ristow KM, Maurer MJ, Macon WR, Colgan JP, Inwards DJ, Ansell SM, Porrata LF, Micallef IN, Johnston PB, Markovic SN, Thompson CA, Nowakowski GS, Witzig TE.

Ann Oncol. 2013 Sep;24(9):2439-43. doi: 10.1093/annonc/mdt188. Epub 2013 May 22.

46.

Low energy (e,2e) coincidence studies of NH3: results from experiment and theory.

Nixon KL, Murray AJ, Chaluvadi H, Ning C, Colgan J, Madison DH.

J Chem Phys. 2013 May 7;138(17):174304. doi: 10.1063/1.4802960.

PMID:
23656131
47.

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

Witzig TE, Wiseman GA, Maurer MJ, Habermann TM, Micallef IN, Nowakowski GS, Ansell SM, Colgan JP, Inwards DJ, Porrata LF, Link BK, Zent CS, Johnston PB, Shanafelt TD, Allmer C, Asmann YW, Gupta M, Ballas ZK, Smith BJ, Weiner GJ.

Am J Hematol. 2013 Jul;88(7):589-93. doi: 10.1002/ajh.23460. Epub 2013 Jun 12.

48.

The Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiation.

Simons AL, Lu P, Gibson-Corley KN, Robinson RA, Meyerholz DK, Colgan JD.

Lab Invest. 2013 Jun;93(6):711-9. doi: 10.1038/labinvest.2013.62. Epub 2013 Apr 22.

49.

Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma.

Porrata LF, Ristow KM, Habermann TM, Macon WR, Witzig TE, Colgan JP, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Nowakowski G, Thompson CA, Markovic SN.

Blood Cancer J. 2013 Apr 19;3:e110. doi: 10.1038/bcj.2013.8.

50.

Exotic dense-matter states pumped by a relativistic laser plasma in the radiation-dominated regime.

Colgan J, Abdallah J Jr, Faenov AY, Pikuz SA, Wagenaars E, Booth N, Culfa O, Dance RJ, Evans RG, Gray RJ, Kaempfer T, Lancaster KL, McKenna P, Rossall AL, Skobelev IY, Schulze KS, Uschmann I, Zhidkov AG, Woolsey NC.

Phys Rev Lett. 2013 Mar 22;110(12):125001. Epub 2013 Mar 18.

Supplemental Content

Loading ...
Support Center